Anticipating Advancements

摘要

Currently, around 1,000 clinical trials are taking place, with over 350 in the gene therapy area and over 30 of the gene therapy products in late-phase studies. While only one licenced product (SparkTherapeutics, Luxturna) is available, the FDA are predicting that 40 products will be licenced by 2020, with an anticipated 10 products being licenced per year.